Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
Issued Date
2022-12-01
Resource Type
ISSN
18623522
eISSN
18623514
Scopus ID
2-s2.0-85132973607
Pubmed ID
35763133
Journal Title
Archives of Osteoporosis
Volume
17
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Archives of Osteoporosis Vol.17 No.1 (2022)
Suggested Citation
Chotiyarnwong P., McCloskey E.V., Harvey N.C., Lorentzon M., Prieto-Alhambra D., Abrahamsen B., Adachi J.D., Borgström F., Bruyere O., Carey J.J., Clark P., Cooper C., Curtis E.M., Dennison E., Diaz-Curiel M., Dimai H.P., Grigorie D., Hiligsmann M., Khashayar P., Lewiecki E.M., Lips P., Lorenc R.S., Ortolani S., Papaioannou A., Silverman S., Sosa M., Szulc P., Ward K.A., Yoshimura N., Kanis J.A. Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group. Archives of Osteoporosis Vol.17 No.1 (2022). doi:10.1007/s11657-022-01117-6 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/85292
Title
Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group
Author(s)
Chotiyarnwong P.
McCloskey E.V.
Harvey N.C.
Lorentzon M.
Prieto-Alhambra D.
Abrahamsen B.
Adachi J.D.
Borgström F.
Bruyere O.
Carey J.J.
Clark P.
Cooper C.
Curtis E.M.
Dennison E.
Diaz-Curiel M.
Dimai H.P.
Grigorie D.
Hiligsmann M.
Khashayar P.
Lewiecki E.M.
Lips P.
Lorenc R.S.
Ortolani S.
Papaioannou A.
Silverman S.
Sosa M.
Szulc P.
Ward K.A.
Yoshimura N.
Kanis J.A.
McCloskey E.V.
Harvey N.C.
Lorentzon M.
Prieto-Alhambra D.
Abrahamsen B.
Adachi J.D.
Borgström F.
Bruyere O.
Carey J.J.
Clark P.
Cooper C.
Curtis E.M.
Dennison E.
Diaz-Curiel M.
Dimai H.P.
Grigorie D.
Hiligsmann M.
Khashayar P.
Lewiecki E.M.
Lips P.
Lorenc R.S.
Ortolani S.
Papaioannou A.
Silverman S.
Sosa M.
Szulc P.
Ward K.A.
Yoshimura N.
Kanis J.A.
Author's Affiliation
Siriraj Hospital
Michael G. DeGroote School of Medicine
Université de Lyon
Ghent university, Center for Microsystems Technology
University Hospital Galway
Universitatea de Medicina si Farmacie Carol Davila din Bucuresti
Universidad Nacional Autónoma de México
McMaster University
University of Oxford
The University of Tokyo
University of Southampton
Hospital Universitario Fundación Jiménez Díaz
Syddansk Universitet
Universiteit Maastricht
Göteborgs Universitet
Cedars-Sinai Medical Center
Karolinska Institutet
C.I. Parhon Institute of Endocrinology
Australian Catholic University
Universidad de Las Palmas de Gran Canaria
The Sheffield Medical School
Vrije Universiteit Amsterdam
University of Galway
IRCCS Istituto Auxologico Italiano
Medizinische Universität Graz
New Mexico Clinical Research and Osteoporosis Center
Holbæk Sygehus
The University of Sheffield
Instituto de Salud Carlos III
Université de Liège
GERAS Centre for Aging Research
SOMED
Quantify Research
Michael G. DeGroote School of Medicine
Université de Lyon
Ghent university, Center for Microsystems Technology
University Hospital Galway
Universitatea de Medicina si Farmacie Carol Davila din Bucuresti
Universidad Nacional Autónoma de México
McMaster University
University of Oxford
The University of Tokyo
University of Southampton
Hospital Universitario Fundación Jiménez Díaz
Syddansk Universitet
Universiteit Maastricht
Göteborgs Universitet
Cedars-Sinai Medical Center
Karolinska Institutet
C.I. Parhon Institute of Endocrinology
Australian Catholic University
Universidad de Las Palmas de Gran Canaria
The Sheffield Medical School
Vrije Universiteit Amsterdam
University of Galway
IRCCS Istituto Auxologico Italiano
Medizinische Universität Graz
New Mexico Clinical Research and Osteoporosis Center
Holbæk Sygehus
The University of Sheffield
Instituto de Salud Carlos III
Université de Liège
GERAS Centre for Aging Research
SOMED
Quantify Research
Other Contributor(s)
Abstract
Summary: The IOF Epidemiology and Quality of Life Working Group has reviewed the potential role of population screening for high hip fracture risk against well-established criteria. The report concludes that such an approach should strongly be considered in many health care systems to reduce the burden of hip fractures. Introduction: The burden of long-term osteoporosis management falls on primary care in most healthcare systems. However, a wide and stable treatment gap exists in many such settings; most of which appears to be secondary to a lack of awareness of fracture risk. Screening is a public health measure for the purpose of identifying individuals who are likely to benefit from further investigations and/or treatment to reduce the risk of a disease or its complications. The purpose of this report was to review the evidence for a potential screening programme to identify postmenopausal women at increased risk of hip fracture. Methods: The approach took well-established criteria for the development of a screening program, adapted by the UK National Screening Committee, and sought the opinion of 20 members of the International Osteoporosis Foundation’s Working Group on Epidemiology and Quality of Life as to whether each criterion was met (yes, partial or no). For each criterion, the evidence base was then reviewed and summarized. Results and Conclusion: The report concludes that evidence supports the proposal that screening for high fracture risk in primary care should strongly be considered for incorporation into many health care systems to reduce the burden of fractures, particularly hip fractures. The key remaining hurdles to overcome are engagement with primary care healthcare professionals, and the implementation of systems that facilitate and maintain the screening program.